Related Podcast
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
2025
Part 3 - Strategies for Educating the APP Community on MASH
2024
What Is the Clinical Profile of Resmetirom, Including Dosing Schedules?
2025
GHAPPcast: Recognizing the Severity of MASH
2025
Part 4 - MASH- What We Don't Know, What We Want to Know
2024
Part 1 - Incorporating the Newly Approved Therapy for MASH into Practice
2024
What is MASH?
2025
How Is MASH Severity Staged? What Would an Ideal MASH NIT Algorithm Look Like?
2025
Part 2 - Using NITs to Identify and Manage MASH Patients
2024
What Are the Consequences of MASH Going Untreated?
2025